These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [Double-blind comparative trial of cefroxadine and cephalexin in the treatment of acute suppurative otitis media and acute exacerbation of chronic suppurative otitis media]. Baba S, Murai K, Kinoshita H, Kawai T, Koyama K, Tsukiyama M, Maruo T, Wada K, Inagaki M, Matsushita T. Jpn J Antibiot; 1983 Sep; 36(9):2595-634. PubMed ID: 6361325 [Abstract] [Full Text] [Related]
65. Treatment of infected dermatoses: a randomized, double-blind clinical trial in general practice. Vallé-Jones JC. Pharmatherapeutica; 1980 Sep; 2(5):293-5. PubMed ID: 7001488 [Abstract] [Full Text] [Related]
69. [Antibacterial efficacy of a new chemotherapeutic agent in acute infections of the upper respiratory tract in childhood. Controlled clinical trial of xibornol and josamycin]. Oggero R, Pugliaro G, Galvagno G, Frigerio M. Minerva Pediatr; 1985 May 31; 37(10):419-24. PubMed ID: 3900675 [No Abstract] [Full Text] [Related]
73. [Evaluation of the clinical efficacy of cefadroxil compared to spiramycin and ampicillin in the treatment of oral infections of dental origin]. Re G, Prencipe R, Moniaci D, Bertone R. Minerva Stomatol; 1982 May 31; 31(6):825-36. PubMed ID: 6761577 [No Abstract] [Full Text] [Related]
76. Comparative efficacy and safety of cephradine and cephalexin in children. Mouallem R. J Int Med Res; 1976 May 31; 4(4):265-71. PubMed ID: 799997 [Abstract] [Full Text] [Related]
77. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes]. Dubreuil L, Devos J, Romond C, Bryskier A. Pathol Biol (Paris); 1986 May 31; 34(5):440-4. PubMed ID: 3534717 [Abstract] [Full Text] [Related]